Literature DB >> 29728063

Antibiotic prescribing behavior among general practitioners - a questionnaire-based study in Germany.

Florian Salm1,2, Sandra Schneider3, Katja Schmücker4, Inga Petruschke4, Tobias S Kramer3, Regina Hanke3,5, Christin Schröder3, Christoph Heintze6, Ulrich Schwantes7, Petra Gastmeier3, Jochen Gensichen8.   

Abstract

BACKGROUND: This study investigates the barriers and facilitators of the use of antibiotics in acute respiratory tract infections by general practitioners (GPs) in Germany.
METHODS: A multidisciplinary team designed and pre-tested a written questionnaire addressing the topics awareness of antimicrobial resistance (7 items), use of antibiotics (9 items), guidelines/sources of information (9 items) and sociodemographic factors (7 items), using a five-point-Likert-scale ("never" to "very often"). The questionnaire was mailed by postally to 987 GPs with registered practices in eastern Germany in May 2015.
RESULTS: 34% (340/987) of the GPs responded to this survey. Most of the participants assumed a multifactorial origin for the rise of multidrug resistant organisms. In addition, 70.2% (239/340) believed that their own prescribing behavior influenced the drug-resistance situation in their area. GPs with longer work experience (> 25 years) assumed less individual influence on drug resistance than their colleagues with less than 7 years experience as practicing physicians (Odds Ratio [OR] 0.32, 95% Confidence Interval [CI] 0.17-0.62; P < 0.001). 99.1% (337/340) of participants were familiar with the "delayed prescription" strategy to reduce antibiotic prescriptions. However, only 29.4% (74/340) answered that they apply it "often" or "very often". GPs working in rural areas were less likely than those working in urban areas to apply delayed prescription.
CONCLUSION: The knowledge on factors causing antimicrobial resistance in bacteria is good among GPs in eastern Germany. However measures to improve rational prescription are not widely implemented yet. Further efforts have to be made in order to improve rational prescription of antibiotic among GPs. Nevertheless, there is a strong awareness of antimicrobial resistance among the participating GPs.

Entities:  

Keywords:  Antibiotic policy; Antibiotic therapy; Antimicrobial resistance; Primary care

Mesh:

Substances:

Year:  2018        PMID: 29728063      PMCID: PMC5935909          DOI: 10.1186/s12879-018-3120-y

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


Background

Antimicrobial resistance (AMR) jeopardizes the achievements of modern medicine in Europe and worldwide [1-3]. The consumption of antibiotics is an important driver of AMR [4, 5]. Over the past decade the global antibiotic use increased significantly [6]. In the human sector the primary use of antibiotics in outpatient care is found among general practitioners (GPs) [7, 8]. There is a considerable difference in outpatient antibiotic use worldwide, between European countries and within countries [9-11]. Considering the use of antibiotics in primary care in Europe, Germany is one of the countries with a lower level of consumption of antibiotics [12, 13]. Nevertheless, it is striking that the proportion of reserve antibiotics in Germany is high [11, 14]. In Germany, the total consumption of antibiotics in human medicine is about 800 tons per year. Approximately 600 tons of this are used in outpatient care [15]. More than half of the antibiotics used in outpatient care are prescribed by GPs in Germany [16, 17]. In GP practices, the majority of antibiotics is prescribed for acute respiratory infections, most of which are caused by a virus [16, 18]. In most cases they do not require antimicrobial therapy [19-22]. In Germany, antimicrobial resistance is mainly a problem in hospital care and especially in intensive care units [23]. German health care system is divided in primary and secondary care, most people are covered by statutory health insurance [24]. The present survey was carried out in the preparation of a broader intervention study, called “Rational antibiotic Use via information and communication” (RAI-project, www.rai-projekt.de). The RAI-project promotes rational antibiotic use in veterinary medicine, in particular in pig farming, as well as in human medicine, surgery and intensive care units, travel medicine, and primary care, with a focus on eastern Germany [25]. The following barriers to rational antibiotic usage have been identified from the scientific literature. But explanations of the barriers to rational antibiotic use vary widely in primary care. Some authors describe that uncertainty about pathogenesis, heavy workflow and patient’s desire for an antibiotic therapy can lead to increased prescription of antibiotics [26-28] as well as knowledge and health literacy among the general population [29]. This questionnaire survey was carried out to examine whether the barriers identified in the literature can also be found in the intervention area.

Methods

Survey development

A multidisciplinary team of the RAI study group developed a questionnaire comprised of 32 questions grouped around the four issues: awareness of antimicrobial resistance (7 items), use of antibiotics (9 items), guidelines/sources of information (9 items) and socio-demographic factors (7 items). The majority of the answers were in tick-box format (see Additional file 1). To identify factors influencing prescribing behavior of antibiotics we conducted a literature review. Based on these results, the questionnaire was developed. The inquiry of the sociodemographic data (Q1-Q4), as well as the questions Q8, Q9, Q12 and Q13 are founded on a previous study conducted among GPs in Germany in 2007 [30]. The questionnaire was pretested among scientists at the Friedrich-Schiller-University (Jena) and the Charité (Berlin). In a second step, a pilot test was conducted among 12 GPs (03/2015). After completing the questionnaire, participants were asked to explain the content of each question in their own words to increase internal validity. GPs who took part in the pilot test were not included in the survey.

Recruitment and data collection

The revised questionnaire was then mailed postally to roughly one third (987) of the GPs from the German federal states of Thuringia, Brandenburg and Berlin (2015/05). In Berlin and Thuringia, pre-existing lists of all registered doctors could be used. In Brandenburg, a list was made available by the Brandenburg Medical Association, with doctors who had agreed to be contacted. Participants were randomly selected from the address lists. In addition to the questionnaire, the letter was accompanied by an addressed and prepaid envelope. The survey was paper based.

Statistical analysis

Differences were tested by Chi-Squared test. A p-value of 0.05 was interpreted as significantly different. For each question, linear logistic regression analysis was performed to estimate predictors for the answers. Socio-demographic factors and a variable for subjective involvement were used as predictors (see Table 1). Participants were classified as subjectively involved when they responded to “How often do you have contact to patients with multi-resistant organisms in daily work?” with “weekly or more often”. All analyses were performed using SPSS [IBM SPSS statistics, Somer, NY, USA] and SAS [SAS Institute, Cary, NC, USA].
Table 1

Demographic characteristics of the participants

ParameterResponder
Gender, female in percent, n (%)212 (62.4)
Mean age in years (SD)51.9 (+/− 8.8)
Mean professional experience in years (SD)16.7 (+/−10.8)
Medical specialist in percent, n (%)
 General Medicine288 (84.7)
 Internal Medicine34 (10)
 None5 (1.5)
 Other11 (3.2)
Population of the practice location, n (%)
  < 5,00056 (16.5)
 5,000–19,00092 (27.1)
 20,000–99,00089 (26.2)
  > 100,000103 (30.3)
Kind of practice, n (%)
 Single practice193 (56.8)
 Joint Practice113 (33.2)
 Practice Communities26 (7.6)
Patient visits per quartile in percent, n (%)
  < 4005 (1.5)
 400–80053 (15.6)
 801–1,200128 (37.6)
 1,201–1,60098 (28.8)
  > 1,60048 (14.1)
Contact with patients with MDRO, n (%)
 Weekly or more often67 (19.7)

Note. All listed parameters were predictors in the multivariable analysis. MDRO multidrug-resistant organism

Demographic characteristics of the participants Note. All listed parameters were predictors in the multivariable analysis. MDRO multidrug-resistant organism

Results

The questionnaire was completed by 340 of 987 (34.4%) GPs. The socio-demographic factors are described in Table 1. Most of the participants were female (62.4%). The mean age was 52 (range 33–78) years and the mean work experience was 16.8 years.

Awareness of antimicrobial resistance

Most of the participants assumed a multifactorial genesis of the rise of multidrug resistant organisms. 80.9% (275/340) of the participants indicated infection control in hospitals, 80.3% (273/340) the use of antibiotics by GPs and 79.1% (261/340) the use of antibiotics in livestock as the main drivers for drug-resistance (multi selection). The majority of participants (70.2%;239/340) believed that their own prescribing behavior influenced the drug-resistance situation in their area. GPs with longer work experience (> 25 years) assumed less individual influence on drug resistance than do their colleagues with less than 7 years experience as practicing physicians (Odds Ration [OR] 0.32, 95% Confidence Interval [CI] 0.17–0.62; P < 0.001).

Guidelines/source of information

Seven percent (23/340) of the participants stated that there is a lack of good guidelines dealing with antibiotic therapy in ambulatory care. Thirty-nine percent (133/340) of the GPs indicated that they frequently use guidelines for antibiotic therapy. Family doctors under the age of 40 made use of guidelines more often than did those older than 60 (OR 3.97, 95%CI 1.32–11.91; P = 0.001). In addition, the location of their place of work (urban vs. rural) influenced the response to this question (Table 2).
Table 2

Results of the multivariable analysis

QuestionsOdds Ratio (95% CI)
Relevance of antimicrobial resistance for daily work(Answers: strong/medium vs. little/not at all)
Contacts to patients with MDRO
Monthly or less frequentlyReference
Weekly or more frequently5.65 (1.71–18.64)
Do you believe that your prescribing behavior influences the drug resistant organism situation in your area?(Answer: yes vs. no or I don’t know)
Work experience
 0–7 yearsReference
 8–14 years0.91 (0.44–1-91)
 14–25 years0.44 (0.23–0.85)
  > 25 years0.32 (0.17–0.62)
Do you use guidelines in your daily routine?(Answers: frequently vs. sometimes, seldom or never)
Population of the practice location
  > 100.000Reference
 20.000–99.0000.93 (0.50–1.73)
 5.000–20.0001.95 (1.07–3.56)
  < 5.0001.08 (0.53–2.19)
Age (in years)
  > 60Reference
 56–603.22 (1.42–7.31)
 51–551.79 (0.76–4.18)
 45–502.99 (1.34–6.65)
 40–443.17 (1.30–7.72)
< 403.97(1.32–11.91)
Do you use the strategy of delayed antibiotic prescription?(Answer: very often/often vs. sometimes/seldom/unknown strategy)
Population of the practice location
  > 100.000Reference
 20.000–99.0000.49 (0.26–0.91)
 5.000–20.0000.39 (0.21–0.75)
  < 5.0000.57 (0.28–1.17)
Indications for me prescribing antibiotics are ……acute infection with yellow/green sputum(rather yes vs. rather not, to a certain degree)
Medical specialization
 General MedicineReference
 Internal Medicine2.36 (1.08–5.17)
 No specialization9.07 (0.85–96.99)
Work experience
 0–7 yearsReference
 8–14 years1.85 (0.90–3.80)
 14–25 years3.33 (1.69–6.58)
  > 25 years6.54 (3.22–13.30)

CI confidence interval, MDRO multidrug resistant organism

Note. Predictors in the multivariable analysis are shown in Table 1

Results of the multivariable analysis CI confidence interval, MDRO multidrug resistant organism Note. Predictors in the multivariable analysis are shown in Table 1

Use of antibiotics

Forty-four percent (151/340) of the GPs stated that one reason for prescribing an antibiotic without a strong indication was that it was just before a weekend when the progression of the infection was difficult to predict. Only 29.4% (74/340) answered that they often or very often apply delayed prescribing, a strategy for dealing with uncomplicated acute respiratory infections in which the use of an antibiotic is recommended to a patient only if the symptoms persist or worsen or further test results come in. 337 of the 340 participants (99.1%) were familiar with this strategy. Thirty-six percent (123/340; Fig. 1) responded that an acute infection with yellow or green sputum is an indication for antibiotic prescription. GPs with more work experience tended to use the color of sputum more often as an indicator for an antimicrobial therapy (> 25 years of working experience vs. < 7 years; OR 6.54, 95% CI 3.22–13.30; P < 0.001).
Fig. 1

Diagnostic value of the sputum color. Answers on the statement: “For me, the indications for an antibiotic prescription are the green colour of the sputum (in the context of an acute respiratory tract infection)” (n = 333)

Diagnostic value of the sputum color. Answers on the statement: “For me, the indications for an antibiotic prescription are the green colour of the sputum (in the context of an acute respiratory tract infection)” (n = 333)

Awareness of antimicrobial resistance and communication aspects

Sixty-eight percent (285/340) of the family doctors stated that they often or very often discuss the subject drug-resistant organisms with patients who have an infection that requires antibiotic therapy; 80.6% (274/340) discuss the subject if the patient does not need antibiotics (Fig. 2). In this survey the main reasons for not discussing this topic were a lack of time (50.6%) and the assumption that their patients were not interested in this subject (42.9%; Fig. 3).
Fig. 2

AMR communication. Answers on the Question: “Do you discuss the topic of antimicrobial resistance (AMR) with patients with an acute infection?” (n = 338)

Fig. 3

AMR missing communication (multiple selection). “Reasons not to talk about antibiotic resistance (AMR).” (n = 338)

AMR communication. Answers on the Question: “Do you discuss the topic of antimicrobial resistance (AMR) with patients with an acute infection?” (n = 338) AMR missing communication (multiple selection). “Reasons not to talk about antibiotic resistance (AMR).” (n = 338)

Discussion

We performed a questionnaire-based survey of general practitioners on patterns of antimicrobial use, patient communication, awareness of rising drug-resistance in primary care and the source of information acquisition. This study demonstrates different specific barriers to rational antibiotic therapy in primary care. First of all, it should be acknowledged that the awareness of antimicrobial resistance among general practitioners has risen during the past few years. In 2007/2008 the Robert Koch Institute distributed a written survey to GPs in Germany. In that survey, 35.8% of the GPs expressed the belief that their prescribing behavior influences drug-resistance in their area [31, 32]. We repeated this question in our survey and 70.2% (239/340) of the participants agreed that their behavior affected drug resistance. This rising awareness might be influenced by international, European and national reports and campaigns that deal with this topic [33-36]. Second, the reliability of sputum color as an indicator for an antimicrobial therapy was overestimated by a majority of the participants. Our investigation found that over one third (36.2%) of the participants use the color as an indication, another third are uncertain (35.9%) and only 25.9% (88/340) of general practitioners do not use sputum color when deciding whether to start antibiotic therapy. Other studies support these findings [28, 37]. In selected diagnoses, especially in chronic lung diseases, the sputum color has a value for antimicrobial therapy decision [38, 39]. Nevertheless, the reproducibility of the evaluation of sputum color has poor inter-rater reliability [40] and is not recommended in the case of an acute respiratory tract infection [41]. In order to work in Germany as a family doctor a 5 year medical specialization in either internal medicine or in general medicine is required. Alternatives to practicing as a general practitioner exist, however rarely. 84.7% (288/340) of the participants have a specialization in general medicine, 10% (34/340) in internal medicine (Table 1). GPs with a specialization in internal medicine were more likely to prescribe an antibiotic based on the color of the sputum than were GPs with a specialization in general medicine (OR 2.36, 95%CI 1.08–5.17; P = 0.03). One explanation for why GPs with a specialization in internal medicine were 2.4 times more likely than participants who specialized in general or family medicine to prescribe antibiotics based on sputum color is that the recommendation not to use the color of the sputum as an indicator is very prominent in the guidelines of the German Society of General Practice and Family Medicine (Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin, DEGAM) [42]. To address the diagnostic uncertainty between a severe acute bronchitis and a starting pneumonia the biomarker as point of care tests are promising [43]. However the reimbursement for GPs in Germany is difficult. An alternative strategy to reduce antibiotic use is delayed prescription [44, 45]. The strategy is well known among the participants (337/340) while only one third (74/340) apply it “often” or “very often”. There is room for improvement in the implementation of the strategy in daily outpatient care, considering the fact that only 21.8% (74/340) use this strategy often and only 7.6% (26/340) very often. Third, some authors emphasize that when GPs feel pressure from their patients, they are more likely to prescribe antibiotics [46-49]. Accordingly, about one third of the participants (102/340) prescribe antibiotics when a patient requests some or when the patient wants to return to work quickly (97/340). However, in this survey general practitioners who felt pressure from their patients remained a minority. Unfortunately, we did not conduct patient interviews to evaluate patient requests for antibiotic therapy. Nevertheless, supported by other authors, we believe that GPs place too much importance on patient requests for antimicrobial therapy [50, 51] . Focusing on aspects of communication, it is striking that a lack of time was the main reason not to talk about antimicrobial resistance (172/340). Some authors describe an antibiotic prescription as an effective means to avoid confrontation and to terminate a consultation [28]. Accordingly, the majority of antibiotic prescriptions are inappropriate in ambulatory care [7]. Patient leaflets could be used for this purpose but there is a lack of established German leaflets for acute respiratory tract infections. There are leaflets of the Center for Disease Control and Prevention (CDC) available in English [52]. This study has certain limitations. All answers are self-reported. Furthermore, as a questionnaire study, this survey contains the risk that respondents will give answers believed to be socially acceptable. The representativeness of the study is limited because the sample was not selected purely randomly, but was instead contacted on the basis of existing address data (self-selection bias). On the other hand, the GPs contacted represent about one third of all GPs working in the region. The response rate is comparable to other studies conducted in Germany [30, 53]. Another limitation is that the questionnaire was only distributed in eastern Germany. This is due to the fact that this survey was performed in preparation for an intervention campaign that started in August 2016 and focused on rational antibiotic use by GPs in eastern Germany. Looking at the socio-demographic parameters of the participants, it is noticeable that they were about 2 years younger (51.9 vs. 54.3) than the GPs average in Germany and were more likely to be female (62.4% vs 41.0 female GPs). There were only minor differences in the type of workplace [54].

Conclusion

When deciding on a therapy, the diagnostic value of sputum color is often overestimated. Delayed prescription is well known but only partially applied. Nevertheless, there is a strong awareness of antimicrobial resistance among the participating GPs. Furthermore, time restrictions disturb doctor-patient communication. Implementation of change to a more rational antibiotic use should address such specific barriers as preconditions to having a sustainable effect. This survey shows clear targets for further approaches to reduce the prevalence of drug-resistant organisms. English version of the survey questionnaire. (DOCX 28 kb)
  38 in total

1.  Antibiotics for acute bronchitis.

Authors:  Susan M Smith; John Smucny; Tom Fahey
Journal:  JAMA       Date:  2014 Dec 24-31       Impact factor: 56.272

2.  Prescribing behaviour in clinical practice: patients' expectations and doctors' perceptions of patients' expectations--a questionnaire study.

Authors:  J Cockburn; S Pit
Journal:  BMJ       Date:  1997-08-30

3.  Antibiotic resistance-the need for global solutions.

Authors:  Ramanan Laxminarayan; Adriano Duse; Chand Wattal; Anita K M Zaidi; Heiman F L Wertheim; Nithima Sumpradit; Erika Vlieghe; Gabriel Levy Hara; Ian M Gould; Herman Goossens; Christina Greko; Anthony D So; Maryam Bigdeli; Göran Tomson; Will Woodhouse; Eva Ombaka; Arturo Quizhpe Peralta; Farah Naz Qamar; Fatima Mir; Sam Kariuki; Zulfiqar A Bhutta; Anthony Coates; Richard Bergstrom; Gerard D Wright; Eric D Brown; Otto Cars
Journal:  Lancet Infect Dis       Date:  2013-11-17       Impact factor: 25.071

4.  A national cross-sectional study on socio-behavioural factors that influence physicians' decisions to begin antimicrobial therapy.

Authors:  E Velasco; W Espelage; M Faber; I Noll; A Ziegelmann; G Krause; T Eckmanns
Journal:  Infection       Date:  2011-06-30       Impact factor: 3.553

5.  Antimicrobial use for pediatric upper respiratory infections: reported practice, actual practice, and parent beliefs.

Authors:  R L Watson; S F Dowell; M Jayaraman; H Keyserling; M Kolczak; B Schwartz
Journal:  Pediatrics       Date:  1999-12       Impact factor: 7.124

6.  Amoxicillin for acute rhinosinusitis: a randomized controlled trial.

Authors:  Jane M Garbutt; Christina Banister; Edward Spitznagel; Jay F Piccirillo
Journal:  JAMA       Date:  2012-02-15       Impact factor: 56.272

7.  Outpatient antibiotic use in Europe and association with resistance: a cross-national database study.

Authors:  Herman Goossens; Matus Ferech; Robert Vander Stichele; Monique Elseviers
Journal:  Lancet       Date:  2005 Feb 12-18       Impact factor: 79.321

8.  Acute cough: a qualitative analysis of how GPs manage the consultation when patients explicitly or implicitly expect antibiotic prescriptions.

Authors:  Attila Altiner; André Knauf; Jette Moebes; Martin Sielk; Stefan Wilm
Journal:  Fam Pract       Date:  2004-10       Impact factor: 2.267

9.  Sputum colour for diagnosis of a bacterial infection in patients with acute cough.

Authors:  Attila Altiner; Stefan Wilm; Walter Däubener; Christiane Bormann; Michael Pentzek; Heinz-Harald Abholz; Martin Scherer
Journal:  Scand J Prim Health Care       Date:  2009       Impact factor: 2.581

10.  Antibiotic use, knowledge and health literacy among the general population in Berlin, Germany and its surrounding rural areas.

Authors:  Florian Salm; Clemens Ernsting; Adelheid Kuhlmey; Melanie Kanzler; Petra Gastmeier; Paul Gellert
Journal:  PLoS One       Date:  2018-02-23       Impact factor: 3.240

View more
  8 in total

Review 1.  Antibiotic prescribing for acute, non-complicated infections in primary care in Germany: baseline assessment in the cluster randomized trial ARena.

Authors:  Regina Poss-Doering; Dorothea Kronsteiner; Martina Kamradt; Edith Andres; Petra Kaufmann-Kolle; Michel Wensing; Joachim Szecsenyi
Journal:  BMC Infect Dis       Date:  2021-08-26       Impact factor: 3.090

2.  Converting habits of antibiotic use for respiratory tract infections in German primary care (CHANGE-3) - process evaluation of a complex intervention.

Authors:  R Poß-Doering; L Kuehn; M Kamradt; K Glassen; Th Fleischhauer; P Kaufmann-Kolle; M Koeppen; A Wollny; A Altiner; M Wensing
Journal:  BMC Fam Pract       Date:  2020-12-19       Impact factor: 2.497

3.  Antimicrobial resistance awareness and antibiotic prescribing behavior among healthcare workers in Nigeria: a national survey.

Authors:  Emelda E Chukwu; David A Oladele; Christian A Enwuru; Peter L Gogwan; Dennis Abuh; Rosemary A Audu; Folasade T Ogunsola
Journal:  BMC Infect Dis       Date:  2021-01-07       Impact factor: 3.090

4.  Fostering Appropriate Antibiotic Use in a Complex Intervention: Mixed-Methods Process Evaluation Alongside the Cluster-Randomized Trial ARena.

Authors:  Regina Poss-Doering; Lukas Kühn; Martina Kamradt; Anna Stürmlinger; Katharina Glassen; Edith Andres; Petra Kaufmann-Kolle; Veit Wambach; Lutz Bader; Joachim Szecsenyi; Michel Wensing
Journal:  Antibiotics (Basel)       Date:  2020-12-08

5.  Evaluation of a multimodal intervention to promote rational antibiotic use in primary care.

Authors:  Inga Petruschke; Florian Salm; Michelle Kaufmann; Antje Freytag; Jochen Gensichen; Michael Behnke; Tobias Siegfried Kramer; Regina Hanke; Petra Gastmeier; Sandra Schneider
Journal:  Antimicrob Resist Infect Control       Date:  2021-04-06       Impact factor: 4.887

Review 6.  Effectiveness of Trainings of General Practitioners on Antibiotic Stewardship: Methods of a Pragmatic Quasi-Experimental Study in a Controlled Before-After Design in South-East-Lower Saxony, Germany (WASA).

Authors:  Daniela Gornyk; Martina Scharlach; Brigitte Buhr-Riehm; Carolina Judith Klett-Tammen; Sveja Eberhard; Jona Theodor Stahmeyer; Anika Großhennig; Andrea Smith; Sarah Meinicke; Wilfried Bautsch; Gérard Krause; Stefanie Castell
Journal:  Front Pharmacol       Date:  2021-04-22       Impact factor: 5.810

7.  Factors Associated With Acceptance of Telehealth-Based Antimicrobial Stewardship Program Recommendations in a Community Hospital Health System.

Authors:  Nathan R Shively; Max W Jacobs; Matthew A Moffa; Rebecca E Schorr; Thomas L Walsh
Journal:  Open Forum Infect Dis       Date:  2022-09-03       Impact factor: 4.423

Review 8.  Antimicrobial stewardship in rural and remote primary health care: a narrative review.

Authors:  Jun Wern Yau; Sze Mun Thor; Danny Tsai; Tobias Speare; Chris Rissel
Journal:  Antimicrob Resist Infect Control       Date:  2021-07-13       Impact factor: 4.887

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.